Want to see BCLI full AI Analyst Report?
Technical Sentiment
Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is 0.11, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 1.03, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 0.90, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Buy.
Brainstorm Cell Therapeutics (BCLI) Pivot Points
Classic
0.93
1.01
1.07
1.15
1.21
1.29
1.35
Fibonacci
1.01
1.06
1.09
1.15
1.20
1.23
1.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Brainstorm Cell Therapeutics (BCLI) Moving Averages
MA5
1.24Sell
1.15Sell
MA10
1.13Sell
1.12Sell
MA20
0.99Buy
1.03Buy
MA50
0.82Buy
0.90Buy
MA100
0.80Buy
0.82Buy
MA200
0.71Buy
0.75Buy
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 1.12, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 0.82, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 0.82, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 0.80, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 0.71, creating a Buy signal.
Brainstorm Cell Therapeutics (BCLI) Technical Indicators
RSI (14)
55.15
Neutral
STOCH (9,6)
31.70
Neutral
STOCHRSI (14)
39.29
Neutral
MACD (12,26)
0.11
Sell
ADX (14)
51.77
Sell
Williams %R
-69.27
Buy
CCI (14)
67.88
Neutral
ATR (14)
0.16
-
Ultimate Oscillator
50.23
Neutral
ROC
25.88
Buy
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 55.15, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 51.77, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is 67.88, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is 25.88, creating a Buy signal.
FAQ
Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Buy.
What is BCLI’s RSI (14)?
BCLI’s RSI (14) is 55.15, which suggests BCLI is a Neutral.
What is BCLI’s MACD?
BCLI’s MACD is 0.11, which suggests BCLI is a Sell.
What is BCLI’s 5-day moving average?
BCLI’s 5-day moving average is 1.24, which suggests BCLI is a Sell.
What is BCLI’s 20-day moving average?
BCLI 20-day moving average is 0.99, which suggests BCLI is a Buy.
What is BCLI’s 50-day moving average?
BCLI’s 50-day moving average is 0.82, which suggests BCLI is a Buy.
What is BCLI’s 200-day moving average?
BCLI’s 200-day moving average is 0.71, which suggests BCLI is a Buy.
What is BCLI’s Williams % R (14)?
BCLI’s Williams % R (14) is -69.27, which suggests BCLI is a Buy.
What is BCLI’s CCI (14)?
BCLI’s CCI (14) is 67.88, which suggests BCLI is a Neutral.